ArticleJournal of hematology & oncology2021

The construction, expression, and enhanced anti-tumor activity of YM101: a bispecific antibody simultaneously targeting TGF-β and PD-L1.

Ming Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.